Status:
COMPLETED
Study Evaluating the Bioavailability of Naproxen 375 mg in Two Formulations
Lead Sponsor:
POZEN
Conditions:
Arthritis
Eligibility:
All Genders
18-55 years
Phase:
PHASE1
Brief Summary
We will evaluate the bioavailability of naproxen 375 mg in two formulations
Eligibility Criteria
Inclusion
- Healthy male or non-pregnant female subjects between 18-55 years as well as other standard inclusion criteria for a study of this nature
Exclusion
- Standard exclusion criteria for a study of this nature
Key Trial Info
Start Date :
June 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 1 2008
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00692055
Start Date
June 1 2008
End Date
July 1 2008
Last Update
September 5 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Austin, Texas, United States